AVE 50.0% 0.3¢ avecho biotechnology limited

elixia asia sales $200 mill within 3 yrs, page-40

  1. 5,322 Posts.
    Dealer I think the really good part of today's new broker report is that it acknowledged POH can build a business and commercialize it on a potentially global scale. I'm reminded of the derision made by many when POH announced it's cosmeceutical strategy to skeptical shareholders and Pohsters. Back on 12 Dec 2009 one of our leading luminaries made the following observation :


    "Elixir tells u a lot about POH's commercial ignorance . Any advertising exec will tell u that at least 1 to 1.5 mil; would be needed on media advertising to launch such a product . Their chances of finding shelf space are zilch .
    Reminds me of Red Earth , even with their own retail outlets the lack of marketing muscle ( read dollars )buried them .POH have got to learn that a good product is only 'part' of the equation . They wont get far with a web site & the odd PR ."

    I won't embarrass this individual by naming names
    But is that humble pie I can smell burning in an oven.....
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.